Sun recalls cancer drug

Share this article:

Sun Pharmaceuticals has racked up its second recall of the year. Reuters reports that the drugmaker has recalled 200 vials of the cancer drug gemcitabine which were distributed in the US. Reuters notes that the voluntary recall, which started in April, was in the “Class II” category which means potential adverse reactions would be temporary.

The generics maker, which recently purchased beleaguered Ranbaxy Pharmaceuticals, recalled 2,528 bottles of its generic Glumetza diabetes drug earlier this year after a patient found epilepsy medication in his bottle.

Share this article:
You must be a registered member of MMM to post a comment.
 

Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.